With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.78 million shares. The 52-week range on NUS shows that it touched its highest point at $14.04 and its lowest point at $5.95 during that stretch. It currently has a 1-year price target of $7.50. With its current market cap of 395.30 million, NUS has annualized dividend of $0.24 while the current yield stands at 3.02%. Beta for the stock currently stands at 1.06.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of NUS was up-trending over the past week, with a rise of 0.38%, but this was up by 23.45% over a month. Three-month performance surged to 6.00% while six-month performance fell -4.79%. The stock lost -36.75% in the past year, while it has gained 15.38% so far this year. A look at the trailing 12-month EPS for NUS yields -2.95 with Next year EPS estimates of 0.75. For the next quarter, that number is 0.13. This implies an EPS growth rate of 18.15% for this year and -24.30% for next year.
Float and Shares Shorts:
At present, 49.80 million NUS shares are outstanding with a float of 47.87 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for NUS since 0 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.68493 being high and $0.65515 being low. For NUS, this leads to a yearly average estimate of $0.675. Based on analyst estimates, the high estimate for the next quarter is $0.24 and the low estimate is $0.24. The average estimate for the next quarter is thus $0.24.
